DA-7867

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H18FN7O3
Molecular Weight	411.3897
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1N=NN=C1C2=CC=C(C=N2)C3=CC=C(C=C3F)N4C[C@H](CNC(C)=O)OC4=O

InChI

InChIKey=XLLXHGCGAQJLLK-AWEZNQCLSA-N

InChI=1S/C19H18FN7O3/c1-11(28)21-9-14-10-27(19(29)30-14)13-4-5-15(16(20)7-13)12-3-6-17(22-8-12)18-23-24-25-26(18)2/h3-8,14H,9-10H2,1-2H3,(H,21,28)/t14-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H18FN7O3
Molecular Weight	411.3897
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.	2006-12	17015632
In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.	2005-10	16189119

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:49:05 GMT 2025` Edited by `admin` on `Mon Mar 31 21:49:05 GMT 2025`
Record UNII	491MT9GU8K
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ACETAMIDE, N-(((5S)-3-(3-FLUORO-4-(6-(1-METHYL-1H-TETRAZOL-5-YL)-3-PYRIDINYL)PHENYL)-2-OXO-5-OXAZOLIDINYL)METHYL)-

Preferred Name

English

DA-7867

Common Name

English

Code System Code Type Description

PUBCHEM

10409343

Created by admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025

PRIMARY

FDA UNII

491MT9GU8K

Created by admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025

PRIMARY

CAS

380382-38-7

Created by admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025

PRIMARY

Related Record Type Details


					491MT9GU8K

DA-7867

ACTIVE MOIETY